DeLuca Richard R. 4
4 · Merck & Co., Inc. · Filed May 2, 2024
Insider Transaction Report
Form 4
DeLuca Richard R.
EVP&Pres, Merck Animal Heallth
Transactions
- Award
Restricted Stock Unit
2024-04-30+23,216→ 23,216 totalFrom: 2027-04-30Exp: 2027-04-30→ Common Stock (23,216 underlying) - Award
Stock Option (Right to Buy)
2024-04-30+37,500→ 37,500 totalExercise: $129.22From: 2025-04-30Exp: 2034-04-29→ Common Stock (37,500 underlying)
Holdings
- 136,593.559
Common Stock
- 1,236.602(indirect: By 401(k))
Common Stock - 401(k) Plan
Footnotes (5)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Includes shares acquired and dividends earned through April 5, 2024 in the Merck U.S. Savings Plan, a 401(k) plan.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F4]These restricted stock units vest in full and are distributed as shares of Merck & Co., Inc. common stock on 04/30/2027.
- [F5]The option vests and becomes exercisable in three equal installments on 4/30/2025, 4/30/2026 and 4/30/2027.